Skip to main content
. 2019 Aug 14;11(4):416–424. doi: 10.3892/mco.2019.1911

Figure 4.

Figure 4.

Comparison of ex-miR-125b levels in the PR, SD and PD groups at the baseline and RECIST judgment points. Ex-miR-125b levels at the baseline and judgment points were compared among the (A) PR, (B) SD and (C) PD groups. Ex-miR-125b, exosomal microRNA-125b; PR, partial response; SD, stable disease; PD, progressive disease; RECIST, Response Evaluation Criteria in Solid Tumors.